New eczema drug shows promise for people with darker skin tones

NCT ID NCT05372419

Completed Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Mar 14, 2026 · Last updated May 05, 2026 · Updated 5 times

Summary

This study tested a drug called lebrikizumab in 90 adults and teens with moderate-to-severe eczema who have skin of color. The goal was to see if the drug safely improves skin symptoms like redness, itching, and rash over 24 weeks. Participants received the drug as an injection, and doctors measured how much their eczema cleared up. This research helps ensure treatments work for all skin types.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Advanced Medical Research

Sandy Springs, Georgia, 30328, United States
Allcutis Research, Inc.

Beverly, Massachusetts, 01915, United States
Arlington Research Center, Inc

Arlington, Texas, 76011, United States
Avance Clinical Trials Inc

Laguna Niguel, California, 92677, United States
Axon Clinical Research

Inglewood, California, 90301, United States
Center For Dermatology Clinical Research, Inc.

Fremont, California, 94538, United States
Clinical Science Institute

Santa Monica, California, 90404, United States
Clinical Trial Network

Houston, Texas, 77074, United States
Complete Dermatology

Sugar Land, Texas, 77479, United States
Cura Clinical Research

Palmdale, California, 93551, United States
Cura Clinical Research

Sherman Oaks, California, 91403, United States
Dawes Fretzin Clinical Research Group, LLC

Indianapolis, Indiana, 46250, United States
Dermatology & Laser Center of Charleston

Charleston, South Carolina, 29407, United States
Dermatology Clinical Research Center of San Antonio

San Antonio, Texas, 78229, United States
Dermatology Research Associates

Los Angeles, California, 90045, United States
Encore Medical Research of Boynton Beach

Boynton Beach, Florida, 33436, United States
First OC Dermatology

Fountain Valley, California, 92708, United States
Miami Dermatology and Laser Research

Miami, Florida, 33173, United States
Oakland Hills Dermatology

Auburn Hills, Michigan, 48326, United States
Progressive Clinical Research

San Antonio, Texas, 78213, United States
PureSkin Dermatology

Orlando, Florida, 32819, United States
Revival Research Institute - Troy

Troy, Michigan, 48084, United States
Sadick Research Group

New York, New York, 10075, United States
Savin Medical Group, LLC

Miami Lakes, Florida, 33014, United States
Skin Care Physicians of Georgia

Macon, Georgia, 31217, United States
Skin Care Research, Inc

Hollywood, Florida, 33021, United States
Skin Specialists, P.C

Omaha, Nebraska, 68144, United States
Solutions Through Advanced Research

Jacksonville, Florida, 32256, United States
Texas Dermatology and Laser Specialists

San Antonio, Texas, 78218, United States
Total Skin and Beauty Dermatology Center, PC

Birmingham, Alabama, 35205, United States
UConn Health

Farmington, Connecticut, 06030-2840, United States
University of California Davis (UC Davis) Comprehensive Cancer Center

Sacramento, California, 95816, United States
Virginia Clinical Research, Inc.

Norfolk, Virginia, 23502, United States
Wallace Medical Group, Inc.

Los Angeles, California, 90056, United States
Washington University School of Medicine

St Louis, Missouri, 63110, United States
Wilmington Health Family Medicine

Wilmington, North Carolina, 28411, United States

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS